Top Markets
#1 Velvet Velvet +31.64%
#2 Prom Prom +31.47%
#3 QuantixAI QuantixAI +31.15%
#4 MowCat MowCat +28.48%
#5 Tutorial Tutorial +24.58%
#6 UnifAI Network UnifAI Network +24.16%
#7 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +21.99%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +20.82%
#9 MarsCoin MarsCoin +18.70%
#10 Versatize Coin Versatize Coin +16.65%
Coin of the day
Velvet Velvet
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
REYON Pharmaceutical Co., Ltd. REYON Pharmaceutical Co., Ltd.

REYON Pharmaceutical Co., Ltd.

102460
Classifica tra le azioni #20565
Operating both domestically in South Korea and across international markets,... Operating both domestically in South Korea and across international markets, REYON Pharmaceutical Co., Ltd. specializes in the production and distribution of pharmaceutical products and active pharmaceutical ingredients (APIs). The company's diverse range of offerings addresses various therapeutic areas, including adrenal corticosteroids; angiotensin II receptor antagonists; anticholinergics; antiemetics; antihypertensives; anti-inflammatory enzymes; lipid-lowering, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer treatments; antispasmodics; benign prostatic hypertrophy therapies; cough and cold remedies; cardiac stimulants; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis medications; local anesthetics; migraine drugs; a variety of cardiovascular system drugs; medications for neuromuscular disorders; nootropics and neurotonics; non-steroidal anti-inflammatory drugs (NSAIDs); respiratory stimulants; skeletal muscle relaxants; and vasodilators. Established in 1955, REYON Pharmaceutical Co., Ltd. maintains its corporate headquarters in Seoul, South Korea.
Prezzo delle azioni
$6.92
Capitalizzazione di mercato
$126.95M
Variazione (1 giorno)
0.10%
Variazione (1 anno)
-11.37%
Paese
KR
Scambia REYON Pharmaceutical Co., Ltd. (102460)

Categoria

Healthcare
Utile per REYON Pharmaceutical Co., Ltd. (102460)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di REYON Pharmaceutical Co., Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di REYON Pharmaceutical Co., Ltd. dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
$1.76B -
IN